Home/Celularity/Vincent LeVien
VL

Vincent LeVien

Director

Celularity

Celularity Pipeline

DrugIndicationPhase
Placental-derived biomaterial productsWound care / Tissue regenerationApproved/Commercial
MLASC-based therapiesDegenerative DiseasesPhase 1/2
NK Cell therapiesOncologyPhase 1/2
T Cell therapiesImmunology/OncologyPhase 1/2